AIP
DNA icon

Almanack Investment Partners’s Ginkgo Bioworks DNA Stock Holding History

Almanack Investment Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-688
Closed -$49.8K – 165
2023
Q3 		$49.8K Buy
+688
New +$55K 0.01% 159
2022
Q4 		– Sell
-50
Closed -$6K – 425
2022
Q3 		$6K Sell
50
-396
-89% -$47.2K ﹤0.01% 554
2022
Q2 		$42K Buy
446
+81
+22% +$9.88K ﹤0.01% 452
2022
Q1 		$59K Buy
+365
New +$71K 0.01% 488

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Almanack Investment Partners's DNA Position: Q4 2023 in Review

Almanack Investment Partners sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 688 shares — an estimated $49.8K sold.

Almanack Investment Partners first reported a position in DNA in Q1 2022 and held it in 4 quarters. The position peaked at $59K in Q1 2022. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

  • Almanack Investment Partners reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
  • Almanack Investment Partners sold 688 Ginkgo Bioworks shares in Q4 2023, an estimated $49.8K.
  • Almanack Investment Partners first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 4 quarters.
  • Almanack Investment Partners's Ginkgo Bioworks position peaked at $59K in Q1 2022.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Almanack Investment Partners's 13F filing for Q4 2023, filed 7 Feb 2024.